NewGenIvf Group Ltd
corporate_fare Company Profile
NewGenIvf Group Ltd (NASDAQ:NIVF) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 43 items for NIVF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-27, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 15 rated 8 or above. Recent SEC coverage for NIVF spans F-3, 6-K/A, 6-K, 424B4.
Recent high-impact activity:
- NewGenIvf Files $100M Universal Shelf With Public Float at Just $1.38M
- NewGenIvf Files Full H1 2026 Financials: $8.04M Net Loss, $6.88M Forbearance Liability
- NewGenIvf Sets 1-for-8 Reverse Split Effective October 23, Cutting Shares to ~1.23M
- NewGenIvf Swings to $8.0M H1 Loss as Derivative and Forbearance Charges Mount
- NewGenIvf Announces Second Reverse Split: 1-for-4 Effective October 12
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 2,470,389 shares in NIVF as of the October 15, 2026 settlement, a 3427.1% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 29, 2026, 67.4% of NIVF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for NIVF, detected from its recent SEC filings · based on capital-structure filings through 2026-10-05.
Deeply Discounted Offering Priced · Massive Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
NIVF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.